Intervention Review

Beclomethasone versus placebo for chronic asthma

  1. Nick P Adams1,*,
  2. Janine C Bestall2,
  3. Reem Malouf3,
  4. Toby J Lasserson4,
  5. Paul Jones5

Editorial Group: Cochrane Airways Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 21 OCT 2004

DOI: 10.1002/14651858.CD002738.pub2

How to Cite

Adams NP, Bestall JC, Malouf R, Lasserson TJ, Jones P. Beclomethasone versus placebo for chronic asthma. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002738. DOI: 10.1002/14651858.CD002738.pub2.

Author Information

  1. 1

    Worthing & Southlands NHS Trust, Respiratory Medicine, Worthing , UK

  2. 2

    St George's Hospital Medical School, Division of Physiological Medicine, London, UK

  3. 3

    Oxfordshire and Buckinghamshire Mental Health Trust, Department of Psychiatry, Oxford, UK

  4. 4

    St George's, University of London, Community Health Sciences, London, UK

  5. 5

    St George's Hospital Medical School, Cardiovascular Medicine, London, UK

*Nick P Adams, Respiratory Medicine, Worthing & Southlands NHS Trust, Worthing , UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2005


Cited in:


This article has been cited by:

  1. 1
    N.P. Adams, P.W. Jones, The dose–response characteristics of inhaled corticosteroids when used to treat asthma: An overview of Cochrane systematic reviews, Respiratory Medicine, 2006, 100, 8, 1297


  2. 2
    Ann Dewey, Anna Bara, Toby J Lasserson, E. Haydn Walters, Colchicine as an oral corticosteroid sparing agent for asthma, The Cochrane Library,